Literature DB >> 7229913

Identifiable pharmacokinetic models: the role of extra inputs and measurements.

K R Godfrey, R P Jones, R F Brown.   

Abstract

Single input, single output experiments can result in nonunique solutions for the rate constants to a linear compartmental model used to describe the pharmacokinetics. Where a finite number of solutions exists, a priori knowledge has to be used to distinguish between the solutions. Where there is a infinite number of solutions, assumptions have to be made about the values of some rate constants in order to obtained a unique solution for the other. This paper considers such experiments and determines whether either the addition of an extra input (simultaneously with the first input) or the taking of an extra measurement would result in a unique solution. It is found that perturbing a second input can be useful, but only if the perturbation is of different shape from the first input. Measurements of drug in urine and metabolite in plasma are generally not helpful in resolving identifiability of the drug dynamic model. If a radioactive tracer is used, through, the second measurement (for example, by externally scanning the radioactivity of the liver) can prove useful, but only if the gain of the measuring device is known.

Mesh:

Substances:

Year:  1980        PMID: 7229913     DOI: 10.1007/bf01060058

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  5 in total

1.  Two-compartment model for a drug and its metabolite: application to acetylsalicylic acid pharmacokinetics.

Authors:  M Rowland; L Z Benet; S Riegelman
Journal:  J Pharm Sci       Date:  1970-03       Impact factor: 3.534

2.  Adequacy of measurements in compartmental modelling of metabolic systems.

Authors:  R F Brown; E R Carson; L Finkelstein; K R Godfrey; R P Jones
Journal:  Med Biol Eng Comput       Date:  1979-03       Impact factor: 2.602

3.  On the definition of the compartment concept in pharmacokinetics.

Authors:  D J Cutler
Journal:  J Theor Biol       Date:  1978-07-20       Impact factor: 2.691

4.  Long-term urinary excretion of methaqualone in a human subject.

Authors:  H D Heck; K Maloney; M Anbar
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

5.  Zinc metabolism in humans: a kinetic model.

Authors:  D M Foster; R L Aamodt; R I Henkin; M Berman
Journal:  Am J Physiol       Date:  1979-11
  5 in total
  10 in total

Review 1.  Combining the 'bottom up' and 'top down' approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data.

Authors:  Nikolaos Tsamandouras; Amin Rostami-Hodjegan; Leon Aarons
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

2.  The design and analysis of parallel experiments to produce structurally identifiable models.

Authors:  S Y Amy Cheung; James W T Yates; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-01-09       Impact factor: 2.745

3.  Structural identifiability analysis of pharmacokinetic models using DAISY: semi-mechanistic gastric emptying models for 13C-octanoic acid.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-02-24       Impact factor: 2.745

4.  Structural identifiability of "first-pass" models.

Authors:  A Venot; E Walter; Y Lecourtier; A Raksanyi; L Chauvelot-Moachon
Journal:  J Pharmacokinet Biopharm       Date:  1987-04

5.  The deterministic identifiability of nonlinear pharmacokinetic models.

Authors:  K R Godfrey; W R Fitch
Journal:  J Pharmacokinet Biopharm       Date:  1984-04

Review 6.  Parameter estimation and uncertainty quantification using information geometry.

Authors:  Jesse A Sharp; Alexander P Browning; Kevin Burrage; Matthew J Simpson
Journal:  J R Soc Interface       Date:  2022-04-27       Impact factor: 4.293

7.  An approach for identifiability of population pharmacokinetic-pharmacodynamic models.

Authors:  V Shivva; J Korell; I G Tucker; S B Duffull
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-06-19

8.  Scale reduction of a systems coagulation model with an application to modeling pharmacokinetic-pharmacodynamic data.

Authors:  A Gulati; G K Isbister; S B Duffull
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-01-08

9.  Modeling Biphasic Environmental Decay of Pathogens and Implications for Risk Analysis.

Authors:  Andrew F Brouwer; Marisa C Eisenberg; Justin V Remais; Philip A Collender; Rafael Meza; Joseph N S Eisenberg
Journal:  Environ Sci Technol       Date:  2017-02-08       Impact factor: 9.028

Review 10.  Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective.

Authors:  Mohamad Shebley; Punam Sandhu; Arian Emami Riedmaier; Masoud Jamei; Rangaraj Narayanan; Aarti Patel; Sheila Annie Peters; Venkatesh Pilla Reddy; Ming Zheng; Loeckie de Zwart; Maud Beneton; Francois Bouzom; Jun Chen; Yuan Chen; Yumi Cleary; Christiane Collins; Gemma L Dickinson; Nassim Djebli; Heidi J Einolf; Iain Gardner; Felix Huth; Faraz Kazmi; Feras Khalil; Jing Lin; Aleksandrs Odinecs; Chirag Patel; Haojing Rong; Edgar Schuck; Pradeep Sharma; Shu-Pei Wu; Yang Xu; Shinji Yamazaki; Kenta Yoshida; Malcolm Rowland
Journal:  Clin Pharmacol Ther       Date:  2018-02-02       Impact factor: 6.875

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.